DXCM
DexCom, Inc.
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Buy
+24/100
Last price
83.40
▼ 3.50 (4.03%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
86.75
Prev close
86.90
Day high
86.75
Day low
82.86
Volume
3.57M
Market cap
$31.47B
P/E (TTM)
34.46
52W range
54.11 – 92.59
Day trading desk
Gap from prior close
-0.17%
Prior close 86.90
VWAP
83.69
-0.35% from price
Relative volume
1.12×
Normal
Session range
5.89%
82.86 – 87.74
Position in range
11%
Near session low
ATR (14D)
1.99
2.38% of price
Prior day high
87.12
PDH
Prior day low
84.75
PDL
Bid / ask spread
—
Quote not published
Session volume
5.00M
Avg 4.48M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-3.75%
-5.7%
1M
-5.13%
-6.3%
3M
+12.60%
+8.1%
6M
+32.13%
+14.0%
YTD
+25.64%
+11.4%
1Y
+24.37%
+8.0%
3Y
-10.62%
-92.9%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on DXCM open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
-73.50K
Net selling
Buy transactions
16
80.44K shares
Sell transactions
19
153.93K shares
Net transactions
+35
Buys less sells
Sell : buy shares
1.9 : 1
Mixed
Insider-held shares
988.68K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 28, 26 | STERN SADIE Officer |
SELL | 2.56K | $220.97K | Direct |
| Sep 15, 26 | AUGUSTINOS NICHOLAS Director |
SELL | 8.09K | $679.77K | Indirect |
| Sep 15, 26 | BROWN MICHAEL JON Officer |
SELL | 1.70K | $142.87K | Direct |
| Sep 10, 26 | BOEHNLEIN GLENN S Director |
STOCK | 5.84K | $0 | Direct |
| Sep 10, 26 | SYLVAIN JEREME M Chief Financial Officer |
SELL | 3.64K | $302.94K | Direct |
| Aug 27, 26 | STERN SADIE Officer |
SELL | 2.56K | $226.67K | Direct |
| Aug 20, 26 | SAYER KEVIN R Officer and Director |
SELL | 26.76K | $2.41M | Direct |
| Aug 14, 26 | BROWN MICHAEL JON Officer |
SELL | 1.70K | $156.28K | Direct |
| Aug 12, 26 | AUGUSTINOS NICHOLAS Director |
STOCK | 1.07K | $0 | Indirect |
| Aug 12, 26 | HELLER BRIDGETTE P Director |
SELL | 1.01K | $89.35K | Direct |
| Aug 3, 26 | FOLETTA MARK G Director |
SELL | 4.00K | $330.64K | Indirect |
| Jul 20, 26 | SAYER KEVIN R Officer and Director |
SELL | 26.76K | $2.04M | Direct |
| Jul 15, 26 | BROWN MICHAEL JON Officer |
SELL | 1.70K | $126.51K | Direct |
| Jul 6, 26 | SAYER KEVIN R Officer and Director |
SELL | 26.76K | $1.93M | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
ALTMAN STEVEN R |
Director | 69.23K | Stock Award(Grant) |
BROWN MICHAEL JON |
Officer | 99.89K | Sale |
COLEMAN JON |
Officer | 95.45K | Sale |
COLLINS RICHARD ALEXANDER |
Director | 45.77K | Stock Award(Grant) |
FOLETTA MARK G |
Director | — | Sale |
LEACH JACOB STEVEN |
Chief Executive Officer | 469.11K | Stock Award(Grant) |
SAYER KEVIN R |
Officer and Director | 302.21K | Sale |
STERN SADIE |
Officer | 123.48K | Sale |
SYLVAIN JEREME M |
Chief Financial Officer | 146.83K | Sale |
TOPOL ERIC J |
Director | 380.55K | Stock Gift |
Fundamentals
Market cap$31.47B
Enterprise value$30.92B
Revenue (TTM)$4.97B
Gross profit$3.10B
EBITDA$1.40B
Net income$999.70M
EPS (TTM)$2.42
Free cash flow$1.02B
Total cash$1.95B
Total debt$1.40B
Book value / share$6.95
Shares outstanding377.36M
Float376.00M
Short % of float5.28%
Dividend yield0.00%
Beta (5Y)1.48
Valuation & profitability ratios
Trailing P/E34.46
Forward P/E26.75
PEG ratio1.34
Price / sales—
Price / book12.01
EV / revenue6.22
EV / EBITDA22.04
Gross margin62.47%
Operating margin24.33%
Profit margin20.12%
Return on equity38.49%
Return on assets10.33%
Debt / equity53.35
Current ratio1.73
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $4.66B | $4.03B | $3.62B | $2.91B | +15.6% |
| Operating revenue | $4.66B | $4.03B | $3.62B | $2.91B | +15.6% |
| Cost of revenue | $1.86B | $1.59B | $1.33B | $1.03B | +16.6% |
| Gross profit | $2.80B | $2.44B | $2.29B | $1.88B | +14.9% |
| Research & development | $599.10M | $552.40M | $505.80M | $484.20M | +8.5% |
| Selling, general & admin | $1.29B | $1.29B | $1.19B | $1.01B | +0.4% |
| Total operating expense | $1.89B | $1.84B | $1.69B | $1.49B | +2.8% |
| Operating income | $911.80M | $600.00M | $597.70M | $391.20M | +52.0% |
| Net interest income | $94.40M | $115.20M | $114.70M | $5.20M | -18.1% |
| Pre-tax income | $1.09B | $709.00M | $710.40M | $390.80M | +53.5% |
| Tax provision | $252.10M | $132.80M | $168.90M | $49.60M | +89.8% |
| Net income | $836.30M | $576.20M | $541.50M | $341.20M | +45.1% |
| Net income to common | $836.30M | $576.20M | $541.50M | $341.20M | +45.1% |
| Basic EPS | 2.14 | 1.46 | 1.40 | 0.88 | +46.6% |
| Diluted EPS | 2.09 | 1.42 | 1.30 | 0.82 | +47.2% |
| EBIT | $1.11B | $728.00M | $730.70M | $409.40M | +52.0% |
| EBITDA | $1.36B | $945.70M | $916.70M | $565.30M | +43.7% |
| Basic shares | 390.20M | 393.60M | 386.00M | 389.40M | -0.9% |
| Diluted shares | 405.50M | 412.70M | 425.50M | 427.50M | -1.7% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $917.70M | $606.10M | $566.30M | $642.30M | +51.4% |
| Accounts receivable | $1.22B | $1.01B | $973.90M | $713.30M | +20.9% |
| Inventory | $629.10M | $542.60M | $559.60M | $306.70M | +15.9% |
| Total current assets | $4.03B | $4.30B | $4.43B | $3.67B | -6.2% |
| Property, plant & equipment | $1.64B | $1.40B | $1.18B | $1.14B | +16.7% |
| Goodwill & intangibles | $95.00M | $126.20M | $159.70M | $199.00M | -24.7% |
| Total assets | $6.34B | $6.48B | $6.26B | $5.39B | -2.2% |
| Total current liabilities | $2.14B | $2.93B | $1.56B | $1.84B | -26.9% |
| Current debt | — | $1.20B | — | $772.60M | — |
| Long-term debt | $1.24B | $1.24B | $2.43B | $1.20B | +0.3% |
| Total debt | $1.39B | $2.59B | $2.59B | $2.15B | -46.3% |
| Total liabilities | $3.59B | $4.38B | $4.20B | $3.26B | -18.0% |
| Retained earnings | $2.43B | $1.60B | $1.02B | $479.90M | +52.3% |
| Shareholder equity | $2.75B | $2.10B | $2.07B | $2.13B | +30.6% |
| Working capital | $1.89B | $1.37B | $2.87B | $1.83B | +38.1% |
| Net tangible assets | $2.65B | $1.98B | $1.91B | $1.93B | +34.1% |
| Shares issued | 410.70M | 408.90M | 407.20M | 393.20M | +0.4% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $836.30M | $576.20M | $541.50M | $341.20M | +45.1% |
| Depreciation & amortisation | $251.80M | $217.70M | $186.00M | $155.90M | +15.7% |
| Stock-based compensation | $159.60M | $170.40M | $150.80M | $126.50M | -6.3% |
| Change in working capital | $103.40M | $108.80M | $3.20M | $26.70M | -5.0% |
| Operating cash flow | $1.44B | $989.50M | $748.50M | $669.50M | +45.6% |
| Capital expenditure | -$363.50M | -$358.80M | -$236.60M | -$364.80M | -1.3% |
| Investing cash flow | $536.00M | -$207.50M | -$507.20M | -$521.50M | +358.3% |
| Share buybacks | -$500.00M | -$750.00M | -$688.70M | -$557.70M | +33.3% |
| Financing cash flow | -$1.69B | -$734.80M | -$318.60M | -$552.50M | -129.5% |
| Free cash flow | $1.08B | $630.70M | $511.90M | $304.70M | +70.8% |
| End cash position | $919.10M | $607.30M | $567.50M | $643.30M | +51.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $1.31B | $1.19B | $1.26B | $1.21B | $1.16B | +9.8% |
| Operating revenue | $1.31B | $1.19B | $1.26B | $1.21B | $1.16B | +9.8% |
| Cost of revenue | $478.40M | $441.60M | $466.90M | $477.90M | $468.30M | +8.3% |
| Gross profit | $830.00M | $750.30M | $792.70M | $731.40M | $688.80M | +10.6% |
| Research & development | $153.00M | $145.30M | $148.20M | $157.50M | $148.20M | +5.3% |
| Selling, general & admin | $358.70M | $349.70M | $321.50M | $331.40M | $328.00M | +2.6% |
| Total operating expense | $511.70M | $495.00M | $469.70M | $488.90M | $476.20M | +3.4% |
| Operating income | $318.30M | $255.30M | $323.00M | $242.50M | $212.60M | +24.7% |
| Net interest income | $13.90M | $16.40M | $19.30M | $28.00M | $23.30M | -15.2% |
| Pre-tax income | $317.50M | $269.50M | $340.70M | $352.30M | $241.10M | +17.8% |
| Tax provision | $68.40M | $70.00M | $73.40M | $68.50M | $61.30M | -2.3% |
| Net income | $249.10M | $199.50M | $267.30M | $283.80M | $179.80M | +24.9% |
| Net income to common | $249.10M | $199.50M | $267.30M | $283.80M | $179.80M | +24.9% |
| Basic EPS | 0.65 | 0.52 | 0.69 | 0.73 | 0.46 | +25.0% |
| Diluted EPS | 0.64 | 0.51 | 0.68 | 0.70 | 0.45 | +25.5% |
| EBIT | $320.50M | $272.60M | $344.90M | $357.00M | $245.80M | +17.6% |
| EBITDA | $388.70M | $339.70M | $410.10M | $420.60M | $308.80M | +14.4% |
| Basic shares | 382.20M | 385.10M | 386.70M | 391.10M | 392.10M | -0.8% |
| Diluted shares | 390.10M | 393.60M | 398.90M | 407.40M | 408.20M | -0.9% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $1.10B | $1.12B | $917.70M | $1.84B | $1.16B | — | -1.2% |
| Cash & short-term investments | $1.95B | $2.42B | $2.00B | $3.32B | $2.93B | — | -19.4% |
| Accounts receivable | $1.26B | $1.09B | $1.22B | $1.11B | $1.35B | — | +15.5% |
| Inventory | $726.40M | $693.60M | $629.10M | $604.10M | $570.70M | — | +4.7% |
| Total current assets | $4.09B | $4.33B | $4.03B | $5.22B | $5.03B | — | -5.7% |
| Property, plant & equipment | $1.67B | $1.63B | $1.64B | $1.53B | $1.51B | — | +2.0% |
| Goodwill & intangibles | $141.10M | $104.90M | $95.00M | $103.10M | $111.30M | — | +34.5% |
| Total assets | $6.46B | $6.63B | $6.34B | $7.50B | $7.33B | — | -2.7% |
| Total current liabilities | $2.36B | $2.22B | $2.14B | $3.34B | $3.31B | — | +6.0% |
| Current debt | — | — | — | $1.21B | $1.21B | $1.21B | — |
| Long-term debt | $1.24B | $1.24B | $1.24B | $1.24B | $1.24B | — | +0.1% |
| Total debt | $1.40B | $1.38B | $1.39B | $2.58B | $2.58B | — | +1.0% |
| Total liabilities | $3.83B | $3.68B | $3.59B | $4.77B | $4.75B | — | +4.3% |
| Retained earnings | $2.88B | $2.63B | $2.43B | $2.17B | $1.88B | — | +9.5% |
| Shareholder equity | $2.62B | $2.96B | $2.75B | $2.73B | $2.57B | — | -11.3% |
| Working capital | $1.73B | $2.11B | $1.89B | $1.88B | $1.72B | — | -18.0% |
| Net tangible assets | $2.48B | $2.85B | $2.65B | $2.62B | $2.46B | — | -13.0% |
| Shares issued | 377.40M | 412.30M | 410.70M | 410.60M | 410.40M | — | -8.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $249.10M | $199.50M | $267.30M | $283.80M | $179.80M | +24.9% |
| Depreciation & amortisation | $68.20M | $67.10M | $65.20M | $63.60M | $63.00M | +1.6% |
| Stock-based compensation | $39.00M | $43.30M | $35.00M | $45.10M | $45.30M | -9.9% |
| Change in working capital | -$97.60M | $214.40M | -$151.00M | $231.60M | $22.40M | -145.5% |
| Operating cash flow | $269.20M | $525.60M | $294.00M | $659.90M | $303.00M | -48.8% |
| Capital expenditure | -$84.70M | -$76.60M | -$101.90M | -$80.50M | -$94.10M | -10.6% |
| Investing cash flow | $329.80M | -$298.50M | $306.60M | $192.80M | -$63.60M | +210.5% |
| Share buybacks | — | — | -$312.80M | -$187.20M | — | — |
| Financing cash flow | -$607.30M | -$25.00M | -$1.52B | -$175.00M | -$1.70M | -2,329.2% |
| Free cash flow | $184.50M | $449.00M | $192.10M | $579.40M | $208.90M | -58.9% |
| End cash position | $1.11B | $1.12B | $919.10M | $1.84B | $1.16B | -1.2% |
Options analytics
Put / call volume
1.33
Put-heavy session
Put / call open interest
0.12
Positioning, not flow
Max pain
86.00
+3.1% from spot
ATM implied vol
49.8%
Nearest strike to spot
Skew (10% OTM)
+1.6%
Puts bid over calls
Call volume
437
Contracts, this expiry
Put volume
581
Contracts, this expiry
Heaviest call OI
90.00
581 contracts
Heaviest put OI
83.00
33 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.61 | 0.70 | +15.1% |
| Mar 2026 | 0.47 | 0.56 | +19.0% |
| Dec 2025 | 0.65 | 0.68 | +4.5% |
| Sep 2025 | 0.57 | 0.61 | +7.5% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.67 | 22 | $1.33B | +9.9% |
| Next quarter | 0.73 | 21 | $1.40B | +11.2% |
| Current year | 2.66 | 25 | $5.23B | +12.2% |
| Next year | 3.12 | 25 | $5.80B | +10.9% |
Analyst targets & ownership
Mean target$95.48
High target$115.00
Low target$79.00
Implied upside14.48%
Analyst count25
ConsensusSTRONG BUY
Strong buy / Buy3 / 22
Hold3
Sell / Strong sell0 / 0
Held by insiders0.26%
Held by institutions106.63%
Institutions holding1.46K
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
86.33
-3.40% from price
SMA 20
86.46
-3.55% from price
SMA 50
86.88
-4.02% from price
SMA 100
79.44
+4.98% from price
SMA 200
73.24
+13.86% from price
EMA 12
86.26
-3.31% from price
EMA 26
86.55
-3.63% from price
EMA 50
84.93
-1.80% from price
RSI (14)
38.9
Neutral
MACD (12,26,9)
-0.29
Hist -0.43
ATR (14)
1.99
2.38% of price
Realised vol 30D
24.1%
Annualised
Bollinger upper
90.12
20, 2σ
Bollinger lower
82.80
20, 2σ
50 / 200 cross
Golden
86.88 vs 73.24
Trend bias
Above 200
+13.86%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.64
Less volatile than market
Correlation to SPY
0.21
Largely independent
Realised vol 30D
24.1%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-22.8%
Peak to trough
Max drawdown 5Y
-66.3%
Peak to trough
ATR 14
1.99
2.38% of price
Beta (reported)
1.48
5Y monthly, from filing
Short interest
Shares short
17.26M
Prior 16.53M
Change vs prior
+4.4%
Shorts adding
% of float
5.28%
Normal
% of shares out
4.57%
Against total outstanding
Days to cover
4.5
Liquid
Float
376.00M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 1, 26 | RBC Capital | MAINTAINED | Outperform | Outperform |
| Sep 18, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| Sep 18, 26 | TD Cowen | MAINTAINED | Buy | Buy |
| Aug 4, 26 | Argus Research | MAINTAINED | Buy | Buy |
| Aug 3, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Jul 31, 26 | Citigroup | MAINTAINED | Buy | Buy |
| Jul 31, 26 | RBC Capital | MAINTAINED | Outperform | Outperform |
| Jul 31, 26 | Mizuho | MAINTAINED | Outperform | Outperform |
| Jul 31, 26 | JP Morgan | MAINTAINED | Neutral | Neutral |
| Jul 31, 26 | Piper Sandler | MAINTAINED | Overweight | Overweight |
| Jul 31, 26 | Wells Fargo | MAINTAINED | Overweight | Overweight |
| Jul 31, 26 | Stifel | MAINTAINED | Buy | Buy |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split4:1
Split dateJun 13, 2022
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-09-14
Corporate Changes & Voting Matters
8-K · 2026-09-10
Periodic Financial Reports
10-Q · 2026-07-30
Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
SD · 2026-05-28
Corporate Changes & Voting Matters
8-K · 2026-05-15
Periodic Financial Reports
10-Q · 2026-04-30
Proxy Statements
DEFA14A · 2026-04-15
Corporate Changes & Voting Matters
8-K · 2026-03-02
Headlines
Dexcom U Enters Season 5 With a Record Roster and Evidence That Diabetes Stigma Among Young Athletes Is Fading
Business Wire · 10h ago
Why Medtronic’s $4 Billion MiniMed Exchange Offer Is Losing Its Allure
Barrons.com · 4d ago
DXCM Report Highlights CGM Growth Opportunity in Type 2 Diabetes Care
Zacks · 5d ago
RBC Raises Price Target on DexCom to $105 From $90, Keeps Outperform Rating
MT Newswires · 6d ago
Tandem Diabetes Care (TNDM) Is Up 7.2% After International Launch Of Mobi Insulin Pump System
Simply Wall St. · 6d ago
Beta Bionics Stock Down Despite iLet-Eversense 365 Integration Deal
Zacks · 8d ago
This Stock Could Be the Big Winner Out of Oura’s IPO
Barrons.com · 8d ago
Tandem Diabetes Expands Insulin Delivery System to 12 New Countries
MT Newswires · 9d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.